Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 8/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1734680 | 0.92 | CYP4F2 (0.46) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL27614308 | 0.91 | CYP4F2 (0.38) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL28343512 | 0.86 | CYP4F2 (0.37) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL27519808 | 0.83 | CYP4F2 (0.48) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL28886961 | 0.83 | CES2 (0.44) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL28545453 | 0.83 | CYP4F2 (0.44) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL3277344 | 0.81 | MEN1 (0.43) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL23754219 | 0.81 | SMPD1 (0.44) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL718008 | 0.81 | CYP4F2 (0.61) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL717168 | 0.81 | CYP4F2 (0.61) | CES2MEN1MAPTKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041731-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240033194-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2024-02-01 | — | — | US | disclosed |
| EP-4267078-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2023-11-01 | — | — | EP | disclosed |
| EP-4267077-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2023-11-01 | — | — | EP | disclosed |
| EP-4262680-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022136507-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | L'OREAL (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136432-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022129286-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| EP-3833319-A1 | BI-PHASE COMPOSITION COMPRISING AN ANTI-TRANSPIRANT OR DEODORANT AGENT | L'OREAL (FR) | 2021-06-16 | — | — | EP | disclosed |
| EP-3166575-B1 | ANHYDROUS SOFT SOLID COMPOSITION BASED ON PARTICLES ENCAPSULATING A BENEFIT AGENT | OREAL (FR) | 2020-04-15 | — | — | EP | disclosed |
| EP-3166586-B1 | ANHYDROUS OIL BASED ON DELIVERY PARTICLES CONTAINING A BENEFIT AGENT | OREAL (FR) | 2020-04-15 | — | — | EP | disclosed |
| WO-2020030784-A1 | BI-PHASE COMPOSITION COMPRISING AN ANTI-TRANSPIRANT OR DEODORANT AGENT | L'OREAL (FR) | 2020-02-13 | — | — | WO | disclosed |
| US-20120100089-A1 | COSMETIC COMPOSITION FOR MAKEUP AND/OR KERATIN MATERIAL CARE, BASED ON A MIXTURE OF RESINS MQ AND T-PR, AND MAKEUP METHOD | L'OREAL (FR) | 2012-04-26 | — | — | US | disclosed |
| US-20120093560-A1 | PACKAGING AND APPLICATOR DEVICE FOR AT LEAST ONE SOLID COSMETIC COMPOSITION | L'OREAL (FR) | 2012-04-19 | — | — | US | disclosed |
| US-20120064019-A1 | COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD | L'OREAL (FR) | 2012-03-15 | — | — | US | disclosed |
| EP-2408333-A1 | A PACKAGING AND APPLICATOR DEVICE FOR AT LEAST ONE SOLID COSMETIC COMPOSITION | L'Oréal (FR) | 2012-01-25 | — | — | EP | disclosed |
| US-20120003167-A1 | COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL | L'OREAL (FR) | 2012-01-05 | — | — | US | disclosed |
| WO-2010106498-A1 | A PACKAGING AND APPLICATOR DEVICE FOR AT LEAST ONE SOLID COSMETIC COMPOSITION | L'OREAL (FR) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041715-A1 | PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT | TRPM5, TRPM6, MSH6 | CES2 3889/4885MEN1 37/4885MAPT 1866/4885 |
| US-20120003167-A1 | COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL | QSOX1, RXRB, PRXL2A | CES2 996/4885MEN1 2593/4885MAPT 4579/4885 |
| US-20120064019-A1 | COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD | PLOD3, ALOX15, ELOVL1 | CES2 3182/4885MEN1 3755/4885MAPT 1721/4885 |
| US-20240041731-A1 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | SCLY, CUTA, ALAD | CES2 852/4885MEN1 2545/4885MAPT 3087/4885 |
| US-20120100089-A1 | COSMETIC COMPOSITION FOR MAKEUP AND/OR KERATIN MATERIAL CARE, BASED ON A MIXTURE OF RESINS MQ AND T-PR, AND MAKEUP METHOD | KRT18, TERB1, VIM | CES2 3953/4885MEN1 1241/4885MAPT 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.